Mayo Test ID GLSF Glucose, Spinal Fluid
Specimen Required
Container/Tube: Plastic vial
Specimen Volume: 1 mL
Collection Instructions: Centrifuge to remove any cellular material.
Useful For
Investigating possible central nervous system infection
Method Name
Photometric, Glucose Oxidase/Peroxidase
Reporting Name
Glucose, CSFSpecimen Type
CSFSpecimen Minimum Volume
0.25 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
CSF | Frozen (preferred) | 30 days | |
Refrigerated | 7 days |
Reject Due To
All specimens will be evaluated at Mayo Clinic Laboratories for test suitability.Clinical Information
Cerebrospinal fluid (CSF) is secreted by the choroid plexuses, around the cerebral vessels, and along the walls of the ventricles of the brain, filling the ventricles and cisternae and bathing the spinal cord. CSF is reabsorbed into the blood through the arachnoid villi. CSF turnover is rapid, exchanging about 4 times per day.
CSF glucose levels may be decreased due to consumption by microorganisms, impaired glucose transport, or increased glycolysis. Elevated CSF glucose levels are consistent with hyperglycemia.
Reference Values
Spinal fluid glucose concentration should be approximately 60% of the plasma/serum concentration and should be compared with concurrently measured plasma/serum glucose for adequate clinical interpretation.
For SI unit Reference Values, see https://www.mayocliniclabs.com/order-tests/si-unit-conversion.html
Interpretation
Cerebrospinal fluid (CSF) glucose levels may be decreased in any central nervous system infection, although levels are typically normal in viral meningitis, low in bacterial meningitis, and may be normal or low in fungal meningitis.
CSF glucose levels are normally about 60% of blood glucose levels.
Cautions
Handle specimens in stoppered containers to avoid contamination and evaporation.
Cerebrospinal fluid specimens should be processed without delay; they may contain cellular constituents, as well as organisms, that lower the concentration of glucose with time.
Clinical Reference
Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. Edited by CA Burtis, ER Ashwood, DE Bruns, St. Louis, MO, Elsevier Saunders, 2012
Method Description
Patient specimen is deposited on the slide where the spreading layer promotes the uniform distribution of the specimen and permits an even penetration of solute molecules into the underlying reagent layer. The oxidation of specimen glucose is catalyzed by glucose oxidase to form hydrogen peroxide and gluconate. The reaction is followed by an oxidative coupling catalyzed by peroxidase in the presence of dye precursors to produce a dye. The intensity of the dye is measured by reflected light.
Each mole of glucose oxidized results in 0.5 mole of dye, assuming quantitative conversions. The intensity of the dye is measured by reflected light at 540 nm and concentration is reported in milligrams per deciliter.(Package insert: Vitros Chemistry Products Instructions for Use-GLU Slides, Ortho-Clinical Diagnostics, Inc. Rochester, NY 14626)
Day(s) Performed
Monday through Sunday
Report Available
Same day/1 daySpecimen Retention Time
1 weekPerforming Laboratory
Mayo Clinic Laboratories in RochesterTest Classification
This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.CPT Code Information
82945
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
GLSF | Glucose, CSF | 2342-4 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
GLSF | Glucose, CSF | 2342-4 |